Lung Transplant Clinical Trial
Official title:
Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation VIP BOLT Trial: A Multicenter Prospective Randomized Trial
The purpose of this research study is to compare the technique of performing bilateral lung transplantation off-pump vs venoarterial ECMO (VA ECMO). The goal of the trial is to determine which technique has lower rates of primary graft dysfunction.
The Investigators of the Extracorporeal Life Support Registry in Lung Transplantation (ECLS Registry) has studied the impact of the type of intraoperative extracorporeal life support on primary graft dysfunction (PGD) after lung transplantation (LTx) in an international registry. The investigators have demonstrated that severe PGD at 48-72 hours is greater when LTx is performed using cardiopulmonary bypass (CPB) (43%) when compared to veno-arterial (VA) ECMO. However, PGD after VA ECMO remained high (29%) when compared to off-pump (12%). Conversely, there are retrospective series showing that when compared to off-pump technique, VA ECMO has reduced PGD rates and improved survival. Because selection bias and unknown confounders in retrospective studies could have been the cause of these conflicting results, part of the ECLS Registry Investigators are committed to a prospective multicenter randomized trial comparing off-pump versus VA ECMO LTx. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05404919 -
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
|
Phase 2 | |
| Completed |
NCT03299504 -
Factors Predicting Success in Lung Transplant Recipients Who Have Undergone Intensive Post-operative Rehabilitation
|
||
| Completed |
NCT00755781 -
Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
|
Phase 3 | |
| Terminated |
NCT03207399 -
Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment
|
Phase 4 | |
| Completed |
NCT03300882 -
PREDICT Cytomegalovirus (CMV)
|
||
| Recruiting |
NCT05101460 -
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
|
||
| Completed |
NCT03150095 -
Health Coaching to Improve Self-Management in Thoracic Transplant Candidates
|
N/A | |
| Completed |
NCT04420195 -
Envarsus XR in Lung Transplant
|
Phase 2 | |
| Recruiting |
NCT02235610 -
Use of Ex Vivo Lung Perfusion (EVLP) in Reconditioning Marginal Donor Lungs for Transplantation
|
N/A | |
| Not yet recruiting |
NCT06066229 -
Identification of Patient Important Outcomes in Lung Transplantation
|
||
| Recruiting |
NCT04601818 -
Planned Semi-Elective Lung Tx Study
|
N/A | |
| Recruiting |
NCT03072589 -
Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation
|
Phase 1 | |
| Completed |
NCT01963780 -
International EXPAND Lung Pivotal Trial
|
N/A | |
| Recruiting |
NCT05671887 -
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
|
||
| Completed |
NCT03987113 -
Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning
|
||
| Recruiting |
NCT02748798 -
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
|
Early Phase 1 | |
| Completed |
NCT03167528 -
Contribution of Learning and Practice of Different Complementary Therapies in Pulmonary Transplant Patients
|
N/A | |
| Active, not recruiting |
NCT04244734 -
Implementation of an Early Rehabilitation Program for the Patient With Lung Transplantation: From the ICU to Home.
|
N/A | |
| Active, not recruiting |
NCT01365429 -
Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs
|
N/A | |
| Recruiting |
NCT05055739 -
Comparative Study Between Sternal Closure With Sternalock® Blue Versus Steel Wire Submitted To Bilateral Anterior Transsternal Thoracotomy (Clamshell) For Bilateral Lung Transplant
|
N/A |